PCLAF and cardiovascular disorder: PTAFR, a membrane protein, specifically binds to platelet‐activating factor (PAF) and mediates various BPs, including immune responses, inflammation, platelet aggregation and vascular regulation, thereby contributing to the progression of diseases such as asthma, cardiovascular disorders and cancer [82–84].